Financing Agreements in the Life Sciences Tools & Services Industry
20 Contracts & Agreements
- ChromaDex Corp. (12 contracts)
- FLUIDIGM CORP (4)
- HARVARD BIOSCIENCE INC (2)
- IQVIA Holdings Inc. (1)
- Syneos Health (1)
- Fifth Modification to Business Financing Agreement dated December 8, 2023 by and among Western Alliance Bank, ChromaDex Corporation, ChromaDex Inc. and ChromaDex Analytics, Inc (ChromaDex Corp., Filed With SEC on December 13, 2023)
- Fourth Modification to Business Financing Agreement dated November 9, 2023 by and among Western Alliance Bank, ChromaDex Corporation, ChromaDex Inc. and ChromaDex Analytics, Inc (ChromaDex Corp., Filed With SEC on December 13, 2023)
- Second Modification to Business Financing Agreement dated November 10, 2021, by and between ChromaDex Corporation and Western Alliance Bank v (ChromaDex Corp., Filed With SEC on March 14, 2022)
- Third Modification to Business Financing Agreement dated December 11, 2021 by and among Western Alliance Bank, ChromaDex Corporation, ChromaDex, Inc. and ChromaDex Analytics, Inc (ChromaDex Corp., Filed With SEC on December 15, 2021)
- Consent to Business Financing Agreement, dated January 14, 2021, by and among Western Alliance Bank and ChromaDex Corporation (ChromaDex Corp., Filed With SEC on May 6, 2021)
- First Modification to Business Financing Agreement dated October 7, 2020, by and between ChromaDex Corporation and Western Alliance Bankv (ChromaDex Corp., Filed With SEC on March 12, 2021)
- Second Amendment to Financing Agreement, dated November 5, 2019, between Harvard Bioscience, Inc., each of the other borrowers named therein, the lenders party thereto, and... (HARVARD BIOSCIENCE INC, Filed With SEC on November 5, 2019)
- Sixth Amendment to the Receivables Financing Agreement, dated September 30, 2019, among Syneos Health Receivables LLC, as borrow (Syneos Health, Filed With SEC on October 31, 2019)
- First Amendment to Financing Agreement, dated as of August 16, 2018, between Harvard Bioscience, Inc., each of the borrowers named therein, the lenders from time to time party... (HARVARD BIOSCIENCE INC, Filed With SEC on November 1, 2018)
- Fifth Business Financing Modification Agreement, dated as of August 21, 2017, by and among Western Alliance Bank, ChromaDex Corporation, ChromaDex, Inc., ChromaDex Analytics, Inc.... (ChromaDex Corp., Filed With SEC on November 9, 2017)
- Fourth Business Financing Modification Agreement, dated as of July 13, 2017, between Western Alliance Bank and ChromaDex Corporation (ChromaDex Corp., Filed With SEC on August 10, 2017)
- Third Business Financing Modification Agreement, dated as of April 19, 2017, between Western Alliance Bank and ChromaDex Corporation (ChromaDex Corp., Filed With SEC on August 10, 2017)
- SECOND BUSINESS FINANCING MODIFICATION AGREEMENT (ChromaDex Corp., Filed With SEC on March 16, 2017)
- FIRST BUSINESS FINANCING MODIFICATION AGREEMENT (ChromaDex Corp., Filed With SEC on March 16, 2017)
- BUSINESS FINANCING AGREEMENT (ChromaDex Corp., Filed With SEC on March 16, 2017)
- RECEIVABLES FINANCING AGREEMENT Dated as of December 5, 2014 by and among QUINTILES FUNDINGLLC, as Borrower, THEPERSONS FROM TIME TO TIME PARTY HERETO, as Lenders, PNC BANK,... (IQVIA Holdings Inc., Filed With SEC on December 8, 2014)
- BUSINESS FINANCING MODIFICATION AGREEMENT (FLUIDIGM CORP, Filed With SEC on January 29, 2014)
- BUSINESS FINANCING MODIFICATION AGREEMENT (FLUIDIGM CORP, Filed With SEC on December 27, 2012)
- BUSINESS FINANCING MODIFICATION AGREEMENT (FLUIDIGM CORP, Filed With SEC on April 4, 2011)
- BUSINESS FINANCING AGREEMENT (FLUIDIGM CORP, Filed With SEC on January 28, 2011)
